IV Equipment Market worth $23.92 billion by 2031

 The IV equipment market is expected to grow significantly, driven by increasing cases of chronic diseases, rising hospitalizations, and an aging population. The demand for safe and reliable devices is driven by the growing use of IV therapy across hospitals, clinics, and home care settings. The introduction of needle-free connectors and smart infusion systems, together with advancements in the healthcare infrastructure in developing countries, is contributing to the enhanced growth of the market.

Browse 400 market data Tables and 65 Figures spread through 400 Pages and in-depth TOC on “IV Equipment Market — Global Forecast to 2031”

IV Equipment Market Size & Forecast:

• Market Size Available for Years: 2025–2031
• 2026 Market Size: USD 17.82 billion
• 2031 Projected Market Size: USD 23.92 billion
• CAGR (2026–2031): 6.1%

IV Equipment Market Trends & Insights:

• The IV catheters segment accounted for the largest share of 37.0% of the market in 2025.
• The medication administration segment accounted for the largest share of 54.9% of the market in 2025.
• The home care settings segment is projected to register the highest CAGR of 7.4% during the forecast period.
• The Asia Pacific is the fastest-growing regional market for IV equipment, at a CAGR of 6.5% during the forecast period.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=78345313

The IV equipment market is experiencing significant growth due to several key factors. The rising prevalence of chronic diseases, such as diabetes, cancer, and cardiovascular conditions, has increased the need for regular hospital care and IV therapies. An aging global population further drives demand, as older patients often require more frequent medical interventions, including surgeries, hydration, and IV administration of nutrients or drugs. In addition, the expansion of healthcare infrastructure in developing regions and greater access to hospitals and clinics have created new markets for IV equipment. Technological advancements are also playing a major role, with safer, more efficient, and user-friendly IV devices being increasingly adopted by healthcare providers. Collectively, these trends are fueling steady growth in the IV equipment industry worldwide.

By type, the needle-free connectors & extension sets segment is expected to register the highest CAGR during the forecast period.

The market is segmented into IV catheters, infusion pumps, IV administration sets & tubing, securement & stabilization devices, needle-free connectors & extension sets, IV drip chambers, and other IV equipment. In 2025, needle-free connectors & extension sets were the fastest-growing segment, driven by their safety, ease of use, and ability to reduce infection risks, making them highly preferred in modern healthcare settings.

By application, the medication administration segment held the largest share of the market in 2025.

The market is segmented into medication administration, parenteral nutrition (PN) fluid & electrolyte replacement, blood & blood products transfusion, diagnostic testing, and other applications. Medication administration accounts for the largest share of the IV equipment market, as intravenous therapy enables direct delivery of drugs into the bloodstream, providing faster therapeutic response, accurate dosing, and improved treatment effectiveness. This application is especially vital in intensive care units, oncology treatments, pain control, and the management of severe infections, where precise and timely drug delivery is essential for better patient outcomes. The rising burden of chronic and acute conditions, coupled with increasing hospital admissions, continues to fuel strong demand for IV-based medication administration.

By end user, home care settings are projected to register the highest growth rate in the IV equipment market.

The market is segmented into hospitals, outpatient infusion & specialty clinics, ambulatory surgical centers (ASCs), home care settings, and other end users. Home care settings are the fastest-growing segment of the IV equipment market, driven by the growing shift toward home-based healthcare and outpatient treatment. Advances in portable, user-friendly IV devices, along with rising demand for long-term therapies such as antibiotic infusions, pain management, and nutritional support at home, are accelerating adoption. Additionally, cost-effectiveness, reduced hospital stays, and improved patient comfort are further contributing to the rapid growth of IV equipment usage in home care settings.

The market in North America is expected to hold the largest share of the IV equipment market throughout the forecast period.

North America dominates the global IV equipment market, driven by the high healthcare expenditure focused on the procurement, upkeep, and advancement of medical technologies. The region’s commitment to addressing the needs of an aging population and maintaining high healthcare standards has led to significant investments in both IV therapy systems and accessories. The Asia Pacific region is projected to experience the highest CAGR in the IV equipment market during the forecast period. This growth is driven by significant advancements in healthcare infrastructure, supported by increased investments in hospitals, clinics, and other medical facilities. As a result, demand for IV equipment and accessories is rising.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=78345313

Top Companies in IV Equipment Market:

The Top Companies in IV Equipment Market include Becton, Dickinson and Company (US), B. Braun SE (Germany), Fresenius SE & Co. KGaA (Germany), ICU Medical, Inc. (US), Terumo Corporation (Japan), Moog Inc. (US), Teleflex Incorporated (US), Cardinal Health (US), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), Baxter (US), Avanos Medical, Inc. (US), Nipro (Japan), JMS Co., Ltd. (Japan), Vygon (France), and Micrel Medical Devices SA (Greece).